Capital Group Investment Management’s Novo Nordisk NVO Stock Holding History

Capital Group Investment Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-5,019	Closed	-$346K	–	144
2025 Q2	$346K	Hold	5,019	–	–	0.06%	135
2025 Q1	$349K	Hold	5,019	–	–	0.07%	135
2024 Q4	$432K	Hold	5,019	–	–	0.08%	133
2024 Q3	$598K	Buy	5,019 +555	+12%	+$74K	0.12%	126
2024 Q2	$637K	Sell	4,464 -256	-5%	-$33.9K	0.14%	122
2024 Q1	$606K	Hold	4,720	–	–	0.11%	162
2023 Q4	$488K	Buy	4,720 +296	+7%	+$29.3K	0.05%	176
2023 Q3	$402K	Sell	4,424 -2,178	-33%	-$192K	0.03%	181
2023 Q2	$534K	Sell	6,602 -1,024	-13%	-$83.7K	0.03%	175
2023 Q1	$607K	Sell	7,626 -1,258	-14%	-$89.2K	0.03%	172
2022 Q4	$601K	Buy	+8,884	New	+$521K	0.02%	184

Other funds holding NVO

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Capital Group Investment Management's NVO Position: Q3 2025 in Review

Capital Group Investment Management sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 5,019 shares — an estimated $346K sold.

Capital Group Investment Management first reported a position in NVO in Q4 2022 and held it in 11 quarters. The position peaked at $637K in Q2 2024. 1,396 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

Capital Group Investment Management reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
Capital Group Investment Management sold 5,019 Novo Nordisk shares in Q3 2025, an estimated $346K.
Capital Group Investment Management first reported a position in Novo Nordisk in Q4 2022 and held it in 11 quarters.
Capital Group Investment Management's Novo Nordisk position peaked at $637K in Q2 2024.
1,396 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Capital Group Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.